Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis
Mingbo Cao, Yuxuan Li, Xiaoping Su, Yongchang Tang, Yupeng Ren, Jing Luo, Feng Yuan, Gaoyuan Yang, Zhiwei He, Zheng Shi, Ziyi Hu, Guirong Liang, Qi Zhang, Meihai Deng, Zhicheng Yao, Nan Lin
Topics & Concepts
ExosomeHepatocellular carcinomaCancer researchLenvatinibCell biologyCytoskeletonMicrovesiclesChemistryMedicineBiologymicroRNACellGeneBiochemistrySorafenibGalectins and Cancer BiologyRNA modifications and cancerCircular RNAs in diseases